Recruiting
Phase 1
Phase 2

VOY-101

Sponsor:

Perceive Biotherapeutics, Inc.

Code:

NCT06087458

Conditions

Age-Related Macular Degeneration

Geographic Atrophy

Non-neovascular AMD

Eligibility Criteria

Sex: All

Age: 60+

Healthy Volunteers: Not accepted

Interventions

VOY-101

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-10-20. This information was provided to ClinicalTrials.gov by Perceive Biotherapeutics, Inc. on 2025-10-15.